Clinical Trials on Immune Thrombocytopenia in Portugal

Total 502 results

Fundación Española de Hematología y Hemoterapía

Recruiting

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

Acquired Thrombotic Thrombocytopenic Purpura

Spain, Portugal
argenx

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia (ADVANCE SC)

Primary Immune Thrombocytopenia

United States, France, Georgia, Germany, Italy, Japan, Poland, Russian Federation, Spain, Turkey, United Kingdom, Argentina, Australia, Bulgaria, Chile, China, Denmark, Greece, Ireland, Israel, Jordan, Korea, Republic of, Mexico, New... and more
argenx

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia (ADVANCE SC+)

Primary Immune Thrombocytopenia

United States, Australia, Bulgaria, China, Georgia, Greece, Italy, Japan, Poland, Portugal, Romania, Russian Federation, Thailand, Turkey, Argentina, Chile, Ireland, Jordan, Tunisia, Korea, Republic of, Mexico, New Zealand, South Africa and more
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

HIV

Portugal
Blueclinical, Ltd.

Completed

Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects

HIV II Infection

Portugal
Universidade do Porto

Unknown

Swimming Pool Environment Impact on the Human Respiratory Health (SWAN)

Asthma | Lung Disease | Genotoxicity

Portugal
University of Minho
Hospital de Braga; Clinical Academic Center (2CA-Braga)

Recruiting

Pain Sensitivity and Psychological Profile of Chronic Low Back Pain Patients

Low Back Pain

Portugal
Universidade do Porto
Centro Hospitalar Universitário de Santo António; Faculty of Medicine (FMUP)

Recruiting

Microvascular Ocular Changes of Systemic Lupus Erythematous (VascLup)

Lupus Erythematosus, Systemic | Eye Manifestations

Portugal
Universidade do Porto

Completed

Meal-Exercise Challenge and Physical Activity Reduction Impact on Immunity and Inflammation (MERIIT)

Obesity | Asthma

Portugal
Universidade do Porto
Centro de Investigação em Tecnologias e Serviços de Saúde (CINTESIS); Rede... and other collaborators

Not yet recruiting

Effect of a Mobile App on Improving Asthma Control in Patients With Persistent Asthma (mINSPIRERS_RCT)

Asthma

Portugal
Instituto de Medicina Molecular João Lobo Antunes
Hospital de Santa Maria, Portugal; IPOFG Lisboa, Portugal; IPOFG Porto, Portugal

Unknown

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease (TREGeneration)

Graft vs Host Disease

Portugal
Universidade do Porto
Aveiro University

Unknown

Safety of Chitosan as Wine Fining Agent in Shrimp Allergic Patients (SWAP)

Shellfish Allergy

Portugal
SOLFARCOS - Pharmaceutical and Cosmetic Solutions...

Completed

Investigate the Safety, Tolerability and Pharmacokinetics of FBL-MTX (FolSmart)

Rheumatoid Arthritis

Portugal
Sociedade Portuguesa de Pneumologia
GlaxoSmithKline

Recruiting

Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients

Severe Asthma

Portugal
Universidade Nova de Lisboa

Recruiting

Effectiveness of Nutrition Education in Carbohydrate Counting in People With Type 1 Diabetic

Type 1 Diabetes

Portugal
Hoffmann-La Roche

Completed

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)

Rheumatoid Arthritis

Portugal
Universidade do Porto

Completed

The JOIN Project: The Air in Diagnosis and Prevention of Asthma and Allergy (JOIN)

Asthma | Atopy

Portugal
Eisai Inc.

Completed

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Thrombocytopenia Associated With Liver Disease

United States, Italy, China, Taiwan, Spain, Belgium, Poland, Portugal, Canada, Korea, Republic of, Australia, Brazil, Chile, Austria, Germany, Hungary, France, Argentina, United Kingdom, Thailand
Universidade Nova de Lisboa
Hospital Particular do Algarve - HPA Saúde

Completed

The Effect of an Anti-inflammatory Diet in Patients With Rheumatoid Arthritis (DAIAR)

Rheumatoid Arthritis

Portugal
Universidade do Porto
Universidade Católica Portuguesa

Completed

Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic Dermatitis (2ndDermisII)

Atopic Dermatitis

Portugal
Novartis Pharmaceuticals

Recruiting

Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

Relapsing Multiple Sclerosis

Portugal
Hoffmann-La Roche

Terminated

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

Rheumatoid Arthritis

Portugal
Cochlear

Completed

Evaluation of Carina Microphone Sensitivity and Maximum Stable Gain in Adult Recipients (CAMSEN)

Hearing Impairment

Portugal
University of Coimbra

Unknown

Evaluation of the Effect of Acupuncture on Hand Pain, Functional Deficits and Health Related Quality of Life in Patients With Rheumatoid Arthritis

Acupuncture

Portugal
Universidade do Porto
Fundação para a Ciência e a Tecnologia; FUNDAÇAO CALOUSTE GULBENKIAN; Sociedade... and other collaborators

Completed

Control and Burden of Asthma and Rhinitis (ICAR)

Asthma | Rhinitis

Portugal
Universidade do Porto
Fundação para a Ciência e a Tecnologia; Instituto de Investigação e Inovação... and other collaborators

Recruiting

Fibrosing ILD Biomarkers That Rule Acceleration (FIBRALUNG)

Pulmonary Fibrosis | Sarcoidosis

Portugal
Universidade do Porto
Sociedade Portuguesa de Alergologia e Imunologia Clinica

Recruiting

Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy (CRD-AIT)

Asthma | Rhinitis, Allergic

Portugal
Universidade do Porto
Research Centre in Physical Activity, Health and Leisure

Recruiting

Exercise as Intervention in Chronic Lymphocytic Leukemia (ADRENALINE)

Chronic Lymphocytic Leukemia

Portugal
Instituto de Medicina Molecular João Lobo Antunes
Merck Sharp & Dohme LLC

Completed

Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis

Rheumatoid Arthritis | Bone Resorption | Ankylosing Spondylitis

Portugal
Association for Innovation and Biomedical Research...

Completed

Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.

Diabetes Mellitus Type II | Diabetes Mellitus Type I | High Risk Proliferative Diabetic Retinopathy

Portugal
Bayer

Completed

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors (POR-BetaPlus)

Secondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)

Portugal
Centro de Reabilitacao do Norte
Aveiro University

Recruiting

RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome (RehabGBs)

Guillain-Barré Syndrome

Portugal
Janssen Research & Development, LLC

No longer available

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

Belgium, Iceland, Portugal, Slovenia
Cough Monitoring Medical Solutions
Universidade Nova de Lisboa

Recruiting

C-mo System 1.0's Validation - Cough Monitoring (C-mo_01)

Chronic Obstructive Pulmonary Disease | Cough | Asthma | Gastro Esophageal Reflux | Idiopathic Pulmonary Fibrosis

Portugal
ACES Entre Douro e Vouga II - Aveiro Norte

Recruiting

Effectiveness of the Rehabilitation Nursing Consultation for People With Asthma on Symptom Control and Quality of Life

Asthma | Rehabilitation | Nursing Caries | Adult | Breathing, Mouth

Portugal
Amgen

Completed

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Cancer | Lung Neoplasms | Non-Small Cell Lung Cancer | Thrombocytopenia | Lung Cancer | Solid Tumors | Oncology | Chemotherapy-Induced Thrombocytopenia

United States, Canada, Italy, Germany, Austria, Hungary, Portugal, Ireland
University of Erlangen-Nürnberg Medical School

Completed

Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain (PreCePRA)

Rheumatoid Arthritis

Germany, Portugal, Serbia
Amgen

Active, not recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer (RECITE)

Chemotherapy-induced Thrombocytopenia

United States, France, Austria, Hungary, Russian Federation, Romania, Spain, Turkey, Greece, Italy, Bulgaria, Canada, Portugal, Argentina, Poland, Mexico, Colombia, Peru, Brazil, Ukraine
Centro Hospitalar de Vila Nova de Gaia/Espinho,...

Not yet recruiting

Effectiveness of Digital Rehabilitation (SIMPLI.REHAB) in Hand Arthritis

Arthritis, Rheumatoid | Arthritis, Psoriatic | Limitation, Mobility | Hand Deformity | Hand Arthritis | Deformity, Hand

Portugal
AbbVie

Completed

Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service (IMPROVE)

Psoriasis | Crohn's Disease | Psoriatic Arthritis | Rheumatoid Arthritis (RA) | Non-radiographic Axial Spondyloarthritis | Ulcerative Colitis (UC) | Ankylosing Spondylitis (AS)

Portugal
Hoffmann-La Roche

Completed

A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs

Rheumatoid Arthritis

Portugal
Novo Nordisk A/S

Completed

Changing Diabetes® World Tour

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

United Arab Emirates, Saudi Arabia, Portugal
Takeda

Completed

A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)

Relapse and/or Refractory Multiple Myeloma

Portugal
Sanofi

Completed

Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis (LEADER)

Arthritis, Rheumatoid

Romania, Portugal, Czech Republic, Italy, Korea, Republic of
Becton, Dickinson and Company

Completed

Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer

Plasma Cell Disorder

Switzerland, Spain, United Kingdom, United States, Portugal
Hospital Clinic of Barcelona
Fundacion Clinic per a la Recerca Biomédica; Brighton and Sussex University... and other collaborators

Unknown

Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE) (EMERGE)

HIV Infections

Spain, Belgium, Croatia, Portugal, United Kingdom
Celgene

Completed

Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma (PrObe-L)

Multiple Myeloma

Portugal
Becton, Dickinson and Company

Completed

BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

Chronic Lymphoproliferative Diseases (CLPD)

Portugal, United States, Spain, Switzerland
DePuy International

Terminated

An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Traumatic Femoral Fractures

Spain, Portugal, United Kingdom, France
Roxall Medicina España S.A

Completed

Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Allergic Rhinoconjunctivitis

Spain, Portugal

Clinical Trials on Immune Thrombocytopenia in Portugal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations